MoneyWorks4Me

Sun Pharma receives EIR from USFDA for inspection at Halol facility

13 Jun 2018 Evaluate

Sun Pharmaceutical Industries has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its Halol facility in the state of Gujarat, during the period February 12-23, 2018.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Peers
Company Name CMP
Sun Pharma. Inds. 1774.25
Dr. Reddys Labs. 1195.05
Cipla 1332.20
Lupin 2006.20
Zydus Lifesciences 1151.90
View more..